Evidence map›Paper›PMID 24121789›Full record

ArticleNature genetics2013

Frequent truncating mutations of STAG2 in bladder cancer.

David A Solomon, Jung-Sik Kim, Jolanta Bondaruk, Shahrokh F Shariat, Zeng-Feng Wang, Abdel G Elkahloun, Tomoko Ozawa, Julia Gerard, Dazhong Zhuang, Shizhen Zhang and 15 more

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Nature genetics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04872036 (Investigation of Prognostic Biomarkers in Patients With Urothelial Carcinoma Treated With Platinum Regimens), which is not on this map. Cited by 125 papers.

0numbers the graph read from it
0cells of the map it votes in
125citing papers in PubMed
19.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04872036 completednot on this map

Investigation of Prognostic Biomarkers in Patients With Urothelial Carcinoma Treated With Platinum Regimens

TypeobservationalSponsorHellenic Cooperative Oncology GroupRan2000 to 2017Enrolled66ConditionsBladder Cancer
3 · Its place in the literature

Who cites it

125 citing papers in PubMed, 223 citations in OpenAlex.

  1. Trial
  2. Trial
  3. STAG2 loss amplifies EWS-FLI1-driven microsatellite enhancer activity promoting Ewing sarcoma aggressiveness.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  4. Article
  5. Cohesin mutations and chromatin changes in cancer.International journal of cancer · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. A STAG2-PAXIP1/PAGR1 axis suppresses lung tumorigenesis.The Journal of experimental medicine · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Role of chromosomal cohesion and separation in aneuploidy and tumorigenesis.Cellular and molecular life sciences : CMLS · 2024
    Review
  20. The synergism of SMC1A cohesin gene silencing and bevacizumab against colorectal cancer.Journal of experimental & clinical cancer research : CR · 2024
    Article

65 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

25 authors at 14 institutions in 3 countries.

David A Solomon1] Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University School of Medicine, Washington, DC, USA. [2] Department of Pathology, University of California, San Francisco, San Francisco, California, USA.
Jung-Sik Kim
Jolanta Bondaruk
Shahrokh F Shariat
Zeng-Feng Wang
Abdel G Elkahloun
Tomoko Ozawa
Julia Gerard
Dazhong Zhuang
Shizhen Zhang
Neema Navai
Arlene Siefker-Radtke
Joanna J Phillips
Brian D Robinson
Mark A Rubin
Björn Volkmer
Richard Hautmann
Rainer Küfer
Pancras C W Hogendoorn
George Netto
Dan Theodorescu
C David James
Bogdan Czerniak
Markku Miettinen
Todd Waldman
The University of Texas MD Anderson Cancer Center · USCornell University · USGeorgetown University · USGeorgetown University Medical Center · USNational Cancer Institute · USUniversity of California, San Francisco · USAlb Fils Kliniken · DEJohns Hopkins Medicine · USKlinikum Kassel · DELeiden University Medical Center · NLNational Human Genome Research Institute · USNeurological Surgery · USUniversity Hospital Ulm · DEUniversity of Colorado Denver · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
Targeting Ral GTPases in Bladder CancerP50CA091846 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI DINNEY, COLIN P.N., MCCONKEY, DAVID J. · 2001 to 2018
$37.4M
NHGRI/DIR Microarray CoreZICHG200365 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI ELKAHLOUN, ABDEL · 2011 to 2025
$9.0M
Analysis of STAG2 Inactivation and Aneuploidy in Human CancerR01CA169345 · NCI · GEORGETOWN UNIVERSITY · PI WALDMAN, TODD A · 2013 to 2017
$1.6M
Cdk4/6 Inhibitor Therapy for Glioblastoma MultiformeR01CA159467 · NCI · GEORGETOWN UNIVERSITY · PI JAMES, CHARLES DAVID, WALDMAN, TODD A · 2012 to 2016
$1.6M
Development and Application of Endogenous Epitope Tagging Technology in Human CelR21CA143282 · NCI · GEORGETOWN UNIVERSITY · PI WALDMAN, TODD A · 2010 to 2011
$361k
Intramural NIH HHSNCI NIH HHS P30 CA016672NCI NIH HHS P50 CA091846NCI NIH HHS P50CA091846NCI NIH HHS R01 CA159467NCI NIH HHS R01CA159467NCI NIH HHS R01 CA169345NCI NIH HHS R01CA169345NCI NIH HHS R21 CA143282NCI NIH HHS R21CA143282
6 · The paper itself

Abstract

Here we report the discovery of truncating mutations of the gene encoding the cohesin subunit STAG2, which regulates sister chromatid cohesion and segregation, in 36% of papillary non-invasive urothelial carcinomas and 16% of invasive urothelial carcinomas of the bladder. Our studies suggest that STAG2 has a role in controlling chromosome number but not the proliferation of bladder cancer cells. These findings identify STAG2 as one of the most commonly mutated genes in bladder cancer.

Indexed as

Codon, NonsenseAnimalsAntigens, NuclearCell Cycle ProteinsCell Line, TumorCohesinsFemaleGene FrequencyHumansMiceMice, Inbred BALB CMice, NudeNeoplasm InvasivenessUrinary Bladder NeoplasmsUrotheliumAntigens, NuclearCell Cycle ProteinsCodon, NonsenseCohesinsSTAG2 protein, human

Identifiers

PMID24121789
PMCPMC3875130
OpenAlexW1973736002

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.